A AZN

Astrazeneca plc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, renowned for its innovative research in the development of prescription medicines across critical therapeutic areas such as oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong and diverse ...

$158.11

-6.80% ($11.54)

Volume 16.30M

52W High $212.71

52W Low $72.71

Market Cap $267.93B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Jul 27, 2026 Beat

Actual: $2.63 vs. Consensus: $2.50

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q2 2026 Jul 27, 2026

1-Day: +1.67%

Q1 2026 Apr 29, 2026

1-Day: +1.17%

5-Day: -0.94%

Q1 2026 Mar 31, 2026

1-Day: +1.78%

Q4 2025 Feb 10, 2026

1-Day: +5.87%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q2'26	$15.19B	+5.1%	73.6%	20.2%	$2.48B
Q1'26	$15.29B	+12.5%	82.5%	27.8%	$3.08B
Q4'25	$15.50B	+4.1%	79.9%	19.2%	$2.33B
Q3'25	$15.19B	+12.0%	81.6%	23.6%	$2.53B
Q2'25	$14.46B	+11.7%	82.9%	24.3%	$2.45B
Q1'25	$13.59B	+7.2%	83.5%	27.0%	$2.92B
Q4'24	$14.89B	+23.8%	81.7%	13.7%	$1.50B
Q3'24	$13.57B	+18.0%	77.3%	15.5%	$1.43B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q2 2026	Jul 27, 2026	$2.50	$2.59	$2.63	+5.20%	Beat
Q1 2026	Apr 29, 2026	$1.27	$2.55	$1.29	+1.57%	Missed
Q1 2026	Mar 31, 2026	$1.27	$1.26	$1.29	+1.43%	Beat
Q4 2025	Feb 10, 2026	$2.10	$2.11	--	--	--
Q3 2025	Nov 6, 2025	$1.13	$1.11	$1.19	+5.31%	Beat
Q3 2025	Sep 30, 2025	$1.13	$1.12	$1.19	+4.87%	Beat
Q2 2025	Jul 29, 2025	$0.88	$1.51	$0.79	-10.23%	Missed
Q2 2025	Jun 30, 2025	$1.46	$1.51	$1.09	-25.90%	Missed
Q1 2025	Apr 29, 2025	$1.12	$1.17	$1.25	+11.61%	Beat
Q1 2025	Mar 31, 2025	$1.12	$1.16	$1.25	+11.59%	Beat
Q4 2024	Feb 6, 2025	$1.04	$1.05	$1.05	+0.96%	Met
Q4 2024	Dec 31, 2024	$1.04	$1.05	$1.05	+0.84%	Met